Hard Course Reactions in February – Here are the strongest ascenders and the bitter disappointments

During February, the development of the Helsinki Stock Exchange pushed to the plus side. From the beginning of February to the last day of the month, the overall index on the stock exchange increased by 3.4 percent. At the beginning of the year, the rise is 9.7 %.

The toughest rising was the airline Finnairwith an increase in February 42.2 percent. Finnair’s share price received support from, for example, a result report published on February 13, whose figures surprised the expectations of analysts.

Finnair returned to the dividend payment and stated in its earnings report that it would propose a dividend of EUR 0.11 for 2024. Analysts following Finnair anticipate an average of EUR 0.05 per share.

The long -plowed electric car charging points also returned to the rise Kempower. During February, Kempower’s rise was 27.3 per cent. Kempower was also positive light spots on the earnings season.

The result of the company’s fourth quarter cut off the thread of three consecutive quarters, even though it was from the comparison period.

Kempower’s comments on the future were optimistic: the company will try to return to growth in 2025 and anticipate net sales by 10-30 %. The company expects to improve significantly since 2024.

Kempower also said it had reached the second-highest order in the company’s history in the last quarter of the market and strengthened its market share in an important North American region.

A strong ascent was also a lifting company Konecraneswhose share price has risen by 17.5 percent during February. Konecranes reports the expected performance improvement in the last quarter of 2024.

CEO of the company Anders Svensson commented in the result report that the orders received improved towards the end of the year and remained close to the previous year’s level.

Also life insurance and asset management company Mandatum February was strong. In February, the company’s share rose 14.6 per cent. The Mandatum course received a stimulant for, among other things, “dividends”, a government dividend proposal of EUR 0.66 per share. The expectations of analysts had a dividend per share per share of EUR 0.35. The dividend consists of a dividend per share of EUR 0.33 in accordance with the dividend policy and a shareholding of EUR 0.33 per share.

(The story goes on after graphics.)

The liquid was a bit of a frustration

The weakest loop of February was definitely a fuel company In thisthe share collapsed during February 29.7 per cent.

Neste reports a comparable EBITDA of EUR 168 million from the last quarter, compared with EUR 797 million in October -December 2023. Analysts anticipate an average of EUR 308 million in comparable EBITDA.

Neste’s Board of Directors proposes that the previous dividend policy be canceled and the company will pay a dividend of EUR 0.20 per share last year. The dividend for 2023 was paid EUR 1.20 per share.

The fluid is particularly pressed on to tighten the competition for renewable products and the increase in capacity, as well as the decline in prices.

February was a bad month also tire company For Nokian Tireswith a share of 22 % per month. Nokian Tires also reported a weaker earnings and cut their dividend into EUR 0.25 per share. The dividend for 2023 was paid EUR 0.55 per share.

The biggest single day bill was the fiber company Spinnovallawhose share on Friday, February 28, fell as much as 43.3 percent. During February, the total decline was 51.8 per cent.

Spinnova said on Friday that the company’s big owner and partner, pulp company Suzano No longer invests in new projects within Spinnova cooperation. According to Spinnova, Suzano’s decision is related to Suzano’s own changed priorities and the allocation strategy of capital and is not related to the lack of trust in Spinnova’s technology.

Spinnova and Suzano have together agreed to start their joint venture Woodspinin strategic evaluation expected to be completed in the coming months. At the same time, Spinnova begins the evaluation of his own strategy, which also applies to all its joint ventures and plans future actions.

There was also a rare situation in February when a listed company BBS-Bioactive Bone Substitutes were bankrupt. BBS, a medical technology company that develops bone implants, justified its bankruptcy application by the fact that the loan negotiations by the company ended without success, which prevents the necessary short -term funding and the continuation of the company.